Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Faes Farma's Enterprise Value is €1,689.1 Mil.
Faes Farma's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €91.3 Mil. Therefore, Faes Farma's EV-to-EBIT ratio for today is 18.51.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Faes Farma's Enterprise Value is €1,689.1 Mil.
Faes Farma's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €120.3 Mil. Therefore, Faes Farma's EV-to-EBITDA ratio for today is 14.04.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Faes Farma's Enterprise Value is €1,689.1 Mil.
Faes Farma's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €610.5 Mil. Therefore, Faes Farma's EV-to-Revenue ratio for today is 2.77.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Faes Farma's Enterprise Value is €1,689.1 Mil.
Faes Farma's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €54.8 Mil. Therefore, Faes Farma's EV-to-FCF ratio for today is 30.80.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Faes Farma (FRA:FFEA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Faes Farma's current Enterprise Value is €1,689.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Faes Farma's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €91.3 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Faes Farma's current Enterprise Value is €1,689.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Faes Farma's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €120.3 Mil.
Faes Farma's current Enterprise Value is €1,689.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Faes Farma's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €610.5 Mil.
Faes Farma's current Enterprise Value is €1,689.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Faes Farma's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €78.5 Mil.
Faes Farma's current Enterprise Value is €1,689.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Faes Farma's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €54.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Faes Farma Enterprise Value Related Terms
Faes Farma Enterprise Value Historical Data
* Premium members only.
The historical data trend for Faes Farma's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:FFEA vs ZTS, UTHR, VTRS: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Faes Farma's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Faes Farma's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of €1,689.1 Mil mean?
Faes Farma (FRA:FFEA) has a Enterprise Value of €1,689.1 Mil as of Jul. 11, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Faes Farma and its competitors.
Is Faes Farma's Enterprise Value too high?
Faes Farma's current Enterprise Value is €1,689.1 Mil. Overall, Faes Farma has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Enterprise Value compare to ZTS and UTHR?
Faes Farma's Enterprise Value of €1,689.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Faes Farma and its competitors. Faes Farma's current Enterprise Value is €1,689.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Based on GuruFocus' analysis, Faes Farma (FRA:FFEA) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.10, compared to a current price of €4.47 — trading 12.4% below its estimated fair value. The current Enterprise Value is €1,689.1 Mil. Faes Farma's overall GF Score™ is 89/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Faes Farma (FRA:FFEA), the current Enterprise Value is €1,689.1 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Faes Farma (FRA:FFEA) Overvalued in 2026?
Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued.
The current stock price of €4.47 is trading 12.4% below its estimated GF Value™ of €5.10.
GuruFocus considers Faes Farma to be Modestly Undervalued.
Key valuation signals for FRA:FFEA:
Enterprise Value: €1,689.1 Mil
GF Value™: €5.10 vs. price of €4.47 (12.4% below fair value)
No single metric tells the full story. See the FRA:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
89GF Score
Get the complete analysis for FRA:FFEA
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FFEA has been successfully added to your 
